Cytotoxic functions of blood mononuclear cells in patients with colorectal carcinoma treated with mAb 17-1A and granulocyte/macrophage-colony-stimulating factor
✍ Scribed by P. Ragnhammar; G. Masucci; J -E Frödin; A -L Hjelm; H. Mellstedt
- Publisher
- Springer-Verlag
- Year
- 1992
- Tongue
- English
- Weight
- 800 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract In general, the mobilization of peripheral blood progenitor cells (PBPC) in multiple myeloma (MM) patients is poor and is achieved in most cases by combined cyclophosphamide and G‐CSF. This study was performed to examine the efficacy of combined ifosfamide/epirubicine and G‐CSF for PBPC
## Abstract Tumor cells might be susceptible to different effector functions of the immune system. This cytotoxic capacity has been utilized to analyze the prognostic significance of peripheral blood mononuclear cells (PBMC) in patients with metastatic colorectal carcinoma (CRC) treated with the mo
## BACKGROUND. Interleukin-2 (IL-2) and granulocyte-macrophageϪcolony stimulating factor (GM-CSF) are cytokines with nonoverlapping pleiotropic effects. In a prior Phase Ib study, this combination of agents exhibited antitumor effects in the lungs of four of eight patients with renal cell carcinoma